Vaxcyte Inc (PCVX)

Stock-Based Compensation

$188.47M

TTM · Period ending: · USD

PCVX logo

PCVX Stock-Based Compensation

Latest reported$188.47M
PCVX Stock-Based Comp ($390.00 → $188.47M)
High-resolution chart · PNG

PCVX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
138,845,000
84,822,000
48,760,000
23,650,000
10,729,000
5,434,000
1,185,000
749,000
390
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.